![GeminX logo](/globalassets/digizuite/25931-geminx-logo-couleur.png?v=4aa9f1)
Exited company
GeminX
Lead
![Ela Borenstein - Vice president, venture capital at BDC](/globalassets/digizuite/12664-ela-borenstein-medium.jpg?v=4a484e)
About the company
Gemin X specialized in the discovery and development of novel therapeutics that modulate apoptosis, the body's natural ability to destroy diseased or damaged cells, in life-threatening diseases. The company is also applying its apoptotic platforms to develop additional products. Apoptosis is an important and normal biological process that plays a vital role in the physiological maintenance of a variety of tissues in the body.
Cephalon acquired Gemin X.